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Abstract: As a field of study, genomic imprinting has
grown rapidly in the last 20 years, with a growing figure of
around 100 imprinted genes known in the mouse and
approximately 50 in the human. The imprinted expression
of genes may be transient and highly tissue-specific, and
there are potentially hundreds of other, as yet undiscov-
ered, imprinted transcripts. The placenta is notable
amongst mammalian organs for its high and prolific
expression of imprinted genes. This review discusses the
development of the human placenta and focuses on the
function of imprinting in this organ. Imprinting is
potentially a mechanism to balance parental resource
allocation and it plays an important role in growth. The
placenta, as the interface between mother and fetus, is
central to prenatal growth control. The expression of
genes subject to parental allelic expression bias has, over
the years, been shown to be essential for the normal
development and physiology of the placenta. In this
review we also discuss the significance of genes that lack
conservation of imprinting between mice and humans,
genes whose imprinted expression is often placental-
specific. Finally, we illustrate the importance of imprinting
in the postnatal human in terms of several human
imprinting disorders, with consideration of the brain as
a key organ for imprinted gene expression after birth.
Introduction
Pronuclear transfer experiments in mice in the early 1980s
showed that maternal and paternal genetic contributions were
non-equivalent and that both were indispensable for normal
development [1,2]. The introduction of reciprocal translocations
into mice, creating regions of uniparental disomy, showed that
discrete areas of the mouse genome were subject to differential
parental regulation [3]. In parallel with this fascinating mouse
work, it was observed that several non-Mendelian human
syndromes showed similar inheritance to phenotypes seen in the
disomic mice [4]. The mapping of deletions causative in Prader
Willi (PWS) and Angelman (AS) syndromes, for example,
permitted localisation of parentally non-equivalent genomic
regions in humans [4]. In 1991, the first endogenous imprinted
genes were identified [5–7]. This parent-of-origin, monoallelic
gene expression, with its associated differential DNA methylation
(first shown in 1993, [8]) became defined as genomic imprinting.
Genomic imprinting, found predominantly in eutherian mam-
mals, is an epigenetic phenomenon whose evolution may be linked
to a dichotomy between paternal and maternal resource
allocation. This is potentially powerful enough to promote
evolution of unequal gene expression between selected parental
alleles. Parental-specific monoallelic expression thus balances fetal
growth to the equal benefit of both parental genomes, in spite of
the resulting potentially damaging haploinsufficiency [9].
The canonical example of allelic expression of imprinted genes
balancing growth is evident with the paternally expressed Igf2 and
maternally expressed Igf2r genes [5,7,10]. Igf2 is a potent enhancer
of fetal growth and inappropriate expression disturbs normal
growth in mice [10]. A reduction in Igf2 expression leads to growth
restriction, whereas biallelic expression and the subsequent
increase in the number of Igf2 transcripts leads to overgrowth
[11,12]. Maternally expressed Igf2r has the opposite effect on
growth, as the Igf2r protein acts as a negative regulator of Igf2 by
binding to the Igf2 protein, reducing its bioavailability and
targeting it for lysosomal degradation [13–16]. Monoallelic
expression of imprinted genes is controlled by allelic DNA
methylation, added differentially to the imprinting control regions
(ICRs) of parental germlines [17,18]. The paternal allelic
expression of murine Igf2 is also found in humans, and in both
species monoallelic expression is mediated in cis by maternal DNA
methylation at the H19 ICR, the differentially methylated domain
(H19 DMD) [19–22].
IGF2 is also an important growth enhancer in humans, and its
expression and subsequent phenotypic effects may be similarly
impacted by dysregulation of imprinting. A loss of methylation at
the H19 DMD in humans is found in a subset of Silver Russell
syndrome (SRS) cases [23]. The main phenotype of SRS is severe
intrauterine growth restriction (IUGR) that could be caused by a
reduction in IGF2 transcription as a result of a loss of methylation at
the H19 DMD [23]. Hypermethylation at the H19 DMD is found
in 30% cases of Beckwith Wiedemann syndrome (BWS) [24], and
the overgrowth macroglossia and organomegaly associated with
this disorder may be caused by an increase in IGF2 transcription as a
result of its biallelic expression. IGF2R imprinting in the human, in
contrast, is polymorphic, rare, and most likely restricted to the
placenta [25]. Recent evidence of a potential human orthologue of
the murine ncRNA Air, responsible in the mouse for paternal Igf2r
silencing, indicates that some key features of reciprocal murine Igf2/
Igf2r imprinting may be present in humans [26].
Human Placental Development
The placenta, particularly the invasive trophoblast lineages, is
an important focus for potential parental conflict. It is directly
responsible for bringing maternal and fetal blood supplies into
contact, facilitating nutrient exchange and determining resource
allocation (Figure 1) [27].
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Human embryos implant interstitially in a highly invasive
manner. Leading edge trophoblast cells fuse to form a syncytium,
resulting in a two layered structure of multinucleated syncytiotro-
phoblast and cellular cytotrophoblast. Protusions of syncytiotro-
phoblast interdigitate into the decidualised endometrium, forming
contacts with the maternal blood supply (Figure 1). Extravillous
cytotrophoblast, which may be analogous to the endoreduplicated
murine giant cells, form columns from the tips of anchoring villae,
attached to the basal plate, and extend through the syncytium.
Invasive cells break away from these columns and migrate to
colonise maternal spiral arteries. Interstitial trophoblast cells
invade to expand the placenta from its edge outwards [28].
Invasion is partly controlled by the decidua, which expresses
proteins, including a wide variety of IGF binding proteins,
balancing invasion and fetal provision [29,30]. Perturbation of
this is evident in ectopic pregnancy, when invasion is far more
extensive in the absence of the decidua [31].
Genomic Imprinting in the Human Placenta
The physiological importance of genomic imprinting in humans
can be demonstrated by the diseases resulting from mutations or
epimutations in imprinted genes. Human imprinting disorders are
somewhat rare but comprise a large group of diverse pathologies,
primarily involving growth or neurological development. Consis-
tent with the growth phenotypes observed, many of the imprinted
genes known to-date are expressed in the human placenta (Table 1)
[32,33].
Disease pathologies resulting from inappropriate imprinted gene
expression may each be due in part, or completely, to an
aberrantly functioning placenta. The placenta is fundamental to
fetal growth, and Table 1 highlights the imprinted genes expressed
in the placenta that have been implicated in fetal growth disorders.
As previously stated, IUGR is a defining characteristic of the
imprinting disorder SRS. Up to half of all SRS cases may be
caused by a reduction in IGF2 expression, as outlined above, but in
the remainder the cause is unknown [23]. Whilst IUGR is often
idiopathic, it is commonly accompanied by reduced blood flow
through the placenta and limited invasion of the decidua and
maternal blood vessels [34]. This phenotype is consistent with
either the loss of expression of an imprinted gene involved in
maximising recruitment of maternal resources (i.e., a paternally
expressed gene), or an increase in expression of an imprinted gene
acting to limit maternal input (i.e., a maternally expressed gene). A
Figure 1. The human fetus and placenta. Villous trophoblasts of the human placenta grow as a branched structure, maximising exchange with
maternal blood. Extravillous trophoblast invade into the maternal endometrium, and some cells colonise maternal spiral arteries, expanding them to
maximise blood flow. ==Paternally expressed; R=maternally expressed. Imprinted genes are important during fetal growth. Some, such as GNAS,
UBE3A, and PLAGL, have physiological impact on the fetus only. Other genes may influence growth in utero via the placenta, or the fetus and
placenta. The IUGR seen in SRS, and overgrowth in BWS are suggestive of a role of IGF2 in the human placenta.
doi:10.1371/journal.pgen.1001015.g001
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second disease associated with reduced placental perfusion is
preeclampsia, whose matrilineal inheritance pattern has highlight-
ed the possibility that imprinted genes might involved in its
pathogenesis [35,36]. In a recent study of 96 cases of BWS, seven
resulted from maternally inherited CDKN1C mutations and of
these, three pregnancies were complicated by preeclampsia,
compared to three of the 89 BWS cases not related to CDKN1C
mutations [37]. Interestingly, transgenic mice whose litters carry
mutations of the maternal Cdkn1c copy display preeclampsia-like
features, including hypertension, proteinuria, and abnormal
trophoblast proliferation [38,39]. These data suggest an important
role for CDKN1C in a subset of preeclampsia cases, however, other
imprinted susceptibility loci for this complication of pregnancy
remain elusive [40].
The imprinted gene PHLDA2 on human Chromosome 11
(Hsa11) is expressed predominately in the placenta, and its
expression in the placenta at term correlates negatively with fetal
birth weight [41]. Given that PHLDA2 is maternally expressed,
Table 1. Imprinted genes expressed in the human placenta, with phenotpyes associated with loss of gain of expression, where
reported.
Locus Gene Active allele Phenotype if biallelic or overexpressed
Phenotype of loss of expression/deletion/
mutation
1p36 TP73 LOI in normal placenta
6q24 PLAGL1* P TNDM (pUPD Hsa6q24, hypomethylation of ICR) Reduced expression in IUGR
7p12 GRB10* P (B) M (T) SRS subset [mUPD7, linkage only] Murine KO exhibit disproportionate fetal and placental
(labyrinth) overgrowth
7q21 TFP12 M None reported
SGCE P Myoclonus dystonia
PEG10* P Hepatocellular carcinoma, linked to IUGR Murine KO lacks spongiotrophoblast
PPP1R9A M Murine KO abnormal dopaminergic signalling
7q32 MEST Iso1* P SRS subset (mUPD7, linkage only) No mutations found.
Murine KO pre- and postnatal growth restriction
MEST Iso2* P
MESTIT1* P
KLF14 M None reported
11p15 H19* M SRS BWS
IGF2* P BWS–Wilm’s+other tumour development SRS
IGF2AS P None reported
INS P Permanent Neonatal Diabetes
KCNQ1* M BWS+Long QT Syndrome 1
KCNQ1OT1* P BWS
CDKN1C* M BWS – abdominal wall defects
SLC22A18* M Unknown but within BWS region
SLC22A18AS* Unknown but within BWS region
PHLDA2* M Decreased birth weight, possible IUGR
Murine overexpression inhibits labyrinth and
spongiotrophoblast growth
Increased birth weight+within BWS linked region
Murine KO show placental hyperplasia, specifically
spongiotrophoblast
14q32 DLK1* P BWS subset. Murine transcgene overexpression
of Dlk1 results in high birth weight but a failure to
thrive [102].
Murine KO show fetal growth restriction, postnatal
catch-up growth and increased adiposity in adults on
high fat diet [103]
15q11 SNRPN P None reported
16p13 ZNF597 M None reported
19q13 ZNF331* M Reduced expression found in IUGR
PEG3 P Ovarian tumours and glioma
Murine KO adults display aberrant maternal care
(females) and sexual behaviour (males)
ZIM2 P None reported
20q13 GNAS XL* P Albright’s hereditary osteodystrophy
GNAS Exon 1A* P Murine KO suckle poorly, lean and growth restricted
with increased insulin sensitivity
NESP M Linked to pseudohypoparathyroidism Type 1b
Murine KO react aberrantly to novelty
*Genes that when mutated/epimutated are associated with a human growth phenotype. Murine phenotypes are also shown where knock-out (KO) models have been
created. UPD, uniparental disomy; TNDM, transient neonatal diabetes mellitus; SRS, Silver Russell Syndrome; BWS, Beckwith Wiedemann Syndrome; P, paternal; M,
maternal; B, brain; T, trophoblast. http://igc.otago.ac.nz/home.html; [33].
doi:10.1371/journal.pgen.1001015.t001
PLoS Genetics | www.plosgenetics.org 3 July 2010 | Volume 6 | Issue 7 | e1001015
this trend is consistent with the parental resource conflict theory,
that maternally expressed genes act to limit maternal resource
provision. Further evidence that PHLDA2 expression levels in the
human placenta might be important in regulating fetal growth
comes from two studies comparing placentas from normal and
IUGR pregnancies. Both studies found higher levels of PHLDA2
expression in placentas from IUGR pregnancies than placentas
from non-IUGR pregnancies [33,42].
Paternally expressed MEST is thought to play a role in
angiogenesis in human trophoblast tissue and decidua, is highly
expressed and robustly imprinted in the placenta [43]. MEST is
located on Hsa7, and maternal uniparental disomy (mUPD) 7, is
implicated in 7–10% of SRS cases. Additionally, one SRS case has
been reported with a segmental mUPD for 7q31-qter, specifically
implicating the MEST imprinting cluster in this instance, rather
than any of the other imprinted genes on Hsa7 [44]. Currently, no
direct evidence exists to link human MEST with disease, but mice
deficient in Mest are pre- and postnatally growth restricted [45].
GRB10 is a growth factor binding protein, maternally expressed
specifically in cytotrophoblast and biallelic elsewhere, located on
Hsa7 [46]. The mUPD7 implicated in 7–10% SRS cases would
lead to biallelic expression of GRB10 and may be linked to the
growth restriction characteristic of SRS for this subset of patients.
Currently, however, no evidence exists to directly link GRB10
expression levels with growth in humans [47,48]. In mouse
embryos, Grb10 is widely expressed from the maternally derived
chromosome, and ablation of this copy causes embryonic
overgrowth, such that neonates are 30% larger than wild-type
littermates at birth [49]. This is accompanied by disproportionate
overgrowth of the placental labyrinth [50].
Imprinting in the Mouse Placenta
Further clues regarding a role for imprinted genes in the
placenta have been derived from studies in transgenic and
knockout mice. Ablating the expression of individual imprinted
genes leads to a range of pathologies, depending on the gene.
Murine paternally expressed Igf2 has been shown to promote
placental growth (see below), and loss of Mest or Peg3 causes
placental growth restriction. Conversely, deletion of maternally
expressed Igf2r, Cdkn1c, or Phlda2 results in placental hyperplasia
[32].
The importance of genomic imprinting specifically in the
murine placenta can be illustrated by the expression pattern of
paternally expressed Igf2. Human and mouse IGF2/Igf2 can be
expressed from several different promoters, but in the mouse, the
transcripts from one promoter—Igf2P0—are placental-specific
[51]. Deletion of the P0 promoter reduces placental size close to
that of complete Igf2 KO, i.e., around 40% smaller than normal
[51]. Humans also have an IGF2 P0 promoter, but it is not
placental-specific, indicating only a partial conservation of
imprinting of IGF2P0/Igf2P0 between mice and humans [52].
The main role of the placenta is the nutrition of the fetus.
Murine Igf2P0 transcripts are expressed specifically in the
labyrinthine trophoblast of the placenta [51], the cellular interface
between the maternal blood supply and the fetal capillaries, and
the surface across which nutrient exchange with the fetus takes
place. Through increasing the surface area, Igf2P0 is thought to
enhance passive permeability in the labyrinth, promoting
nutrient exchange [51,53]. In the Igf2P0-null model, fetal Igf2
expression is shown to regulate nutrient supply from the growth-
restricted placenta in a paracrine manner [51]. The presence of
circulating fetal Igf2 coincident with an imbalance between
placental supply and fetal demand results in upregulation of
nutrient transfer systems [54]. Placental transcription of glucose
transporter Slc2a3 and paternally expressed amino acid transporter
Slc38a4 are upregulated, followed by an increase in glucose and
amino acid transport from the placenta to the fetus [54]. These
data show that imprinted growth regulators may influence nutrient
supply through action in the placenta, or by regulating demand
from the fetus.
As previously discussed, the expression level of PHLDA2/Phlda2
correlates inversely with fetal growth in both humans and mice
[33,41,55]. This role as a growth suppressor has recently been
directly linked with the exchange of nutrients between mother and
fetus in mice [56]. In a transgenic model, a two-fold increase in
Phlda2 expression resulted in reduced placental weight, specifically
in the junctional zone, and a decrease in glycogen stores and
glycogen cell migration, important for fetal glucose supplies late in
gestation [56]. This is the reverse of what is seen in the Phlda2
knockout mouse, and unlike the null, impacted on embryonic as
well as placental development so that overexpression of Phlda2 led
to 13% reduction in fetal weight [55,56]. These data suggest that
the regulation of fetal and placental growth by PHLDA2/Phlda2
might be effected through its potential role in nutrient transfer [56].
The KCNQ1/Kcnq1 Imprinting Cluster
Expression within the KCNQ1/Kcnq1 imprinting cluster on
Hsa11/Mmu7 is only partially conserved between humans and
mice [25]. Whilst the central six transcripts, covering 400 kb,
maintain monoallelic expression in both species, the eight flanking
genes are known to be maternally expressed in the mouse and
bovine placenta, extending the imprinted domain to 780 kb [57–
59]. In contrast, these flanking transcripts are biallelic in the
human [25] (Figure 2).
The function of several of the genes in the KCNQ1/Kcnq1 cluster
has been extensively characterised, and correspond with roles in
embryonic and placental growth. ASCL2/Ascl2 is essential for early
placental development, whilst CDKN1C/Cdkn1c is a growth
suppressor, whose absence causes neonatal lethality in the mouse
[60,61]. Mutations or epimutations affecting CDKN1C result in
one type of BWS in the human, commonly involving severe
abdominal wall defects [62,63]. Another group of BWS cases are
due to mutations or epimutations immediately upstream of H19.
These BWS patients have a high risk of tumours, especially
compared to the CDKN1C region (epi)mutation group; see Table 1
[63]. KCNQ1 is imprinted at the majority of expressed sites in the
human, except in the heart, the site of the defect in long-QT
syndrome that are caused by mutations in KCNQ1 [64,65].
PHLDA2, whose role has already been discussed, is also encoded at
this locus.
A differentially methylated region (DMR) in intron 10 of
KCNQ1 acts dually as the imprinting control region (ICR) for the
cluster, called KvDMR, and the promoter of an antisense ncRNA
KCNQ1OT1, which contributes to the regulation of imprinting at
the domain [66,67] (Figure 2). In the mouse, this ncRNA is
imprinted and expressed from the paternally inherited chromo-
some where its transcription is required for the repression of the
paternally inherited protein coding genes in cis [68,69]. Kcnq1ot1
RNA may be linked to recruitment of the Eed-Ezh2 polycomb
protein complex to the paternal chromosome, resulting in the
enrichment of H3K27Me3 and H3K9Me2 and a repressed
chromatin conformation conducive to allelic silencing [58].
Dnmt12/2 mice are deficient in DNA methytransferase DNMT1,
the enzyme responsible for maintenance of DNA methylation. In
these mice, histone modifications are able to maintain imprinting
of the placental specific genes in the Kcnq1 region, indicating that
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maintenance methylation is not required for prolonged mono-
allelic expression of these genes in the placenta. Imprinting of the
central six genes is lost in Dnmt12/2 mice [57,58,70], indicating
that they do require maintenance methylation for monoallelic
expression. Despite the absence of a requirement for maintenance
methylation for the imprinting of a subset of genes in this cluster,
the establishment of the germline DMR (by different enzymes, the
de novo DNA methyltransferase, Dnmt3a [71]) remains essential for
imprinting across the whole locus [70]. There is evidence that the
murine Kcnq1ot1 RNA may form a silencing compartment in the
nucleus, to which the repressed alleles are localised [72]. This
compartment is larger in the murine placenta than in the fetus,
perhaps reflecting the increased size of the repressed region in this
tissue [73]. Given that imprinting of the KCNQ1 region in the
human embryo and placenta both mirror that of the mouse
embryo, if this model is correct it may be that such a
transcriptional silencing compartment would be smaller in the
human placenta, encompassing only the central seven transcripts.
Differences in the Placenta Between Humans and
Mice
The placenta is the organ with the most varied morphology
between mammalian species [74]. This is indicative of the different
reproductive strategies employed by different species, where young
may be precocial or altricial, and litter size and gestational length
vary greatly. The lack of conservation of imprinting between
humans and mice in the placenta, such as that of IGF2PO and the
KCNQ1 region, has been suggested to be due to the marked
differences between murine and human placentation and
pregnancy [75,76]. Mice have a labyrinthine interdigitation into
the maternal decidua, compared to the villous structure of the
exchange surface in the human. Mouse placentas have one or very
few central maternal arteries, but in the human, several maternal
spiral arteries provide the placenta with nutrients and oxygen. In
the mouse, glycogen cells in the placenta become abundant
between E13 and E18.5, invade the decidua basalis, and cluster at
the base of the central maternal artery. They lyse just before term,
possibly to provide energy for the final phase of prenatal growth
[77]. Both species manipulate the maternal blood supply to
maximise nutrient transfer. In the mouse, it is suggested that the
primary cause of maternal artery transformation is the secretion of
cytokines—i.e., by glycogen cells, which secrete Igf2 protein and
express nuclear Cdkn1c and have been shown to be important for
transformation of the central maternal artery [78,79]. Artery
transformation in the mouse is shallow and limited to the proximal
decidua [75]. Conversely, human maternal arteries are extensively
colonised by endovascular trophoblast cells. These cells relax the
elastic artery walls and expand the lumen, allowing increased
blood flow to the growing human fetus.
Differences in Imprinted Gene Expression
Between Human and Mouse Placentas
In the mouse, 5–15 fetuses may be carried in utero at the same
time, depending on the mouse strain, and one pregnancy can
occur from two separate matings [80,81]. This intra-brood
competition forms the basis of one of the key features of the
parental conflict theory because such a scenario would be
predicted to increase parental conflict at the materno-placenta
interface [82]. Different levels of conflict in the placenta between
mice and humans may account for the divergence in imprinted
gene expression profiles, with imprinted expression of certain
genes not being required in the human. The transcriptional
regulator Ascl2 is imprinted in the mouse placenta, and absolutely
required for placentation, whereas in the human this gene is
biallelically expressed, indicative of a less stringent requirement for
dosage management in humans for this gene [60,83,84], or the
utilisation of a different mechanism of dosage control in the
human. Sheep, like humans, bear singletons and the sheep
orthologue of placental specific Ascl2 (SASH2), is biallelically
expressed whilst CDKN1C is maternally expressed [85]. To date,
most genes that are imprinted in mouse but not in human,
including those previously discussed, are imprinted specifically in
the placenta of the mouse. Table 2 lists placental-specific
imprinted genes identified in the mouse at several loci. With the
exception of TFPI2 these genes are not imprinted in the human
[25]. This observation lends support to the idea that the placenta
could be at the centre of the differences in imprinting between
mice and humans. Of the genes listed in Table 2, most are
maternally expressed, consistent with an involvement of these
genes in limiting placental and/or fetal growth [25]. Perhaps the
mouse placenta manages parental conflict through a more limited
invasion of the maternal decidua and blood vessels than that of the
human placenta, with imprinted genes playing a role in
modulating the process.
Total reproductive capability of mammalian females over a
lifetime could also have an impact on parental conflict, and so
possibly imprinted gene expression, since deleterious effects of
pregnancy on the mother may be additive between pregnancies. It
would therefore be illuminating to compare imprinting in
monoseasonally oestrous species, such as the giant panda, with
imprinting in mammals capable of many fertile oestrous cycles in
their lifetimes, such as mice and humans.
Figure 2. The KCNQ1/Kcnq1 imprinted gene cluster. The KCNQ1/Kcnq1 region on human Chromosome 11/mouse Chromosome 7 is the largest
known imprinting cluster in mice. The central KCNQ1OT1 transcript is paternally expressed and executes silencing of the other transcripts on this
allele, so the rest are maternally expressed only. The region is smaller in the mouse fetus than the placenta, and this feature is not conserved in the
human where the flanking transcripts are universally biallelic. CARS and TSPAN32 are not imprinted and are shown with a white back ground to reflect
this.
doi:10.1371/journal.pgen.1001015.g002
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Changes in Global Gene Expression in the
Placenta during Gestation
Genome-wide expression analyses of early and late murine and
human placentas show that early placentation events are more
similar between mammalian species than later placental growth
[86]. During early gestation and placental developmental stages—
i.e., E8.5 to E10.5 in the mouse—the placenta utilises evolution-
arily ancient genes, such as those involved in metabolism, the cell
cycle, and RNA processing. During mid to late gestation (E10.5 to
E15) a transition occurs where expression profiles become
enriched for genes that evolved since the divergence of rodents
and primates from their common ancestor. In rodents, from E15
to P0 genes specific to the rodent placenta are expressed, and in
the human placenta primate-specific genes are all enriched
compared to the mouse [86].
This striking selection for high expression of evolutionarily new,
species-specific genes, during mid-gestation with specificity
increasing as gestation continues, is indicative of the progressive
divergence of placental physiology during development. Concom-
itantly, the conservation of genomic imprinting between humans
and mice may be dynamic through pregnancy. Imprinting can be
developmentally regulated by epigenetic regulators that are tissue-
specific. Germline methylation can therefore be ‘‘read’’ differently
in different cell types and at different stages in development,
resulting in, for example, the highly tissue-specific imprinting at
the GNAS locus on Hsa20/Mmu2 [87]. Differential reading of the
germline methylation mark could depend on the presence of
tissue-specific transcription factors or epigenetic effectors such as
polycomb group proteins. For example, allelic histone modifica-
tions in the Kcnq1 region are required to maintain imprinting of
placental-specific imprinted genes in the mouse placenta and are
able to do so without maintenance of differential methylation at
the KvDMR, which is not the case for the genes imprinted in the
embryo that still require an intact KvDMR [57,58]. As placental
physiology diverged throughout gestation, differences in develop-
mentally regulated imprinting may also have evolved. It is possible
that placental-specific imprinting seen in the mouse (Table 2) may
be present in the human placenta, but at a much earlier gestation
than has so far been analysed, before differentiation resulted in
biallelic expression of these genes. Similarly, in later gestation in
humans, genes not imprinted in the mouse may be imprinted in
the human placenta.
Imprinting in the Postnatal Human
After birth, resource allocation is distinct from that during
pregnancy, and the interaction between offspring and mother is
vastly changed. The placenta, and its function to transfer nutrients
from the maternal bloodstream and pass them on to the fetus, is no
longer present, and the neonate has developed strategies to
function ex utero, leading to full independence after weaning. Key
organs for imprinted expression postnatally include the brain and
endocrine tissues, such as brown adipose tissue, which regulates
non-shivering thermogenesis, a pre-weaning postnatal adaptation
to independent life [88]. Genes whose imprinted expression was
previously vital in the placenta, may cease to be important in some
tissues, exemplified by the biallelic expression of IGF2 in human
adult liver [89].
It is likely that parental conflict in mammals therefore continues
after birth, albeit in an altered fashion (Figure 3) [90]. During the
period between weaning and independence of children from their
parents, the father has an increased role given his position as
‘‘breadwinner’’ that may be an investment of higher magnitude
than that of the mother in older children [91,92]. Postnatally,
some aspects of several imprinting syndromes seem incompatible
with the conflict theory in its simplest form. For example, PWS
results from a loss of paternally expressed transcripts, yet PWS
children are characteristically large. This can be reconciled with
the concept of resource allocation by focussing on behaviour.
Genes imprinted in the PWS/AS region, which are highly
expressed in the brain, may act postnatally to modify behaviour
to maximise resources (Figure 3). Emotional and behavioural cues
could be utilised by the neonate to manipulate parents in order to
provide adequate nutrition. In AS, caused by loss of expression of
maternally expressed UBE3A, children prolong suckling and
exhibit convivial behaviour that maximises maternal input [93].
In PWS, resulting from the loss of paternally expressed HBII-85
snoRNAs, children suckle badly and wean quickly but are
hyperphagic after birth, arguably maximising utilisation of
paternal resources and minimising usage of maternal ones
[94,95]. So, conflict exists after birth, but its arena might be
considered to have moved from the placenta to the brain [92].
Whether this facet of imprinting displays consistency between
humans and mice remains to be seen. Mouse models with targeted
deletions of the MBII-85 snoRNA cluster display characteristic
PWS features of hypotonia and a failure to thrive, followed by
hyperphagia [96,97]. The mice do not become obese, indicating
some species-specific differences in metabolism, however the
behavioural parallels between between PWS and the MBII-85-
deleted transgenic mouse indicate that some aspects of postnatal
conflict may be managed similarly between the two species
[96,97]. Imprinting in the brain is conserved between mice and
humans at the GRB10/Grb10 locus, where transcripts are
paternally expressed in the central nervous system through similar
tissue specific chromatin modifications [46,98–100]. Grb10 is a
growth inhibitor and is maternally expressed in most tissues in
mouse [49]. In utero, Grb10 negatively regulates fetal and
placental growth, whilst it is involved in glucose homeostasis in
adult muscle and adipose tissue [101]. The function of Grb10 in
Table 2. Conservation of imprints in human and mouse
http://igc.otago.ac.nz.
Gene (murine notation) Mouse Human
Gatm Imprinted in placenta Not imprinted
Igf2r, Air Imprinted Not imprinted/No
orthologue
Pon 2, 3, Asb4, Imprinted in placenta Not imprinted
Nap1l4, Osbpl5, Cd81,
Ltrpc5, Tssc4, Ascl2
Imprinted in placenta Not imprinted
Ampd3, Th, Dhcr7 Imprinted in placenta Not imprinted
Dcn Imprinted in placenta Not imprinted
Slc22a2, Slc22a3 Imprinted in placenta Not imprinted
(SLC22A2
polymorphic)
Xist/Tsix Imprinted in placenta
throughout gestation, and
in preimplantation embryo
Not imprinted
Many genes in the mouse are imprinted specifically in the placenta. A lack of
conservation exists between the human and the mouse, where these placental-
specific genes are not imprinted at all in the human. Of these genes, all except
Air and Tsix are maternally expressed, and except Igf2r, Air and Ascl2, are all
confined either in their expression or their imprinting to the placenta
[25,46,52,104].
doi:10.1371/journal.pgen.1001015.t002
PLoS Genetics | www.plosgenetics.org 6 July 2010 | Volume 6 | Issue 7 | e1001015
brain and the purpose of its maternal suppression is unknown. The
distinct mechanism of GRB10/Grb10 regulation observed in
human and mouse brain [46,100], and opposing allelic repression
compared to other tissues, is suggestive of it having a distinct role
in this tissue, perhaps in influencing postnatal behaviour in the
father’s favour [46]. Imprinting in the brain is a developing field,
one that will provide new and exciting insights into human
behaviour and the evolution of imprinting.
Summary
The biological function of reducing the diploid state to
functional haploidy has to be questioned in terms of its
evolutionary significance. A case needs to be made for the benefit
of silencing of one parental allele balanced against the negative
impact of a mutation at the remaining allele that would leave the
cell with no gene product.
In humans, inappropriate expression of imprinted genes leads in
many cases to severe syndromes. This shows that the monoallelic
expression of this small subset of genes is indispensible for normal
human development. Aberrant prenatal growth occurs frequently in
imprinting syndromes. This shows that an important feature of
imprinting is the regulation of growth and nutrient transfer between
mother and fetus, for which the placenta is key. This regulation
should be balanced to serve the interests of both parents equally.
There are several genes that are imprinted in mice but not in
humans. This is suggestive of a difference in importance or
function of these transcripts between these two species, possibly
due to species-specific differences in their respective placental
physiology. The lack of conservation in imprinted expression for
some genes may also be linked to a reduction in conflict during
human pregnancy compared to the mouse, as humans bear
singletons rather than large litters, and so have little or no
possibility of multiple paternity.
Whilst differences in the reproductive biology of mice and
humans are evident, large distinctions in imprinting in organs
unrelated to pregnancy have not yet been identified. Following
birth, offspring are free frommaternal growth constraints, no longer
rely on the placenta and must now recruit input from both parents
in order to maximise fitness. A resolution of parental conflict
postnatally will therefore rely on specific behavioural and emotional
cues, engaging organs such as the brain and endocrine axis.
Genomic imprinting in humans is clearly important. Analysis of
imprinting disorders and information from closely related
Figure 3. Maternal and paternal resource allocation before and after birth. Before birth and during weaning the mother’s role in fetal
nutrition and support far outweighs the father. Following weaning the role of the father increases. The placenta is only involved in utero; following
this, the brain is likely to be the organ most important in the drive for resources. Expression of imprinted genes, acting as resource enhancers (RE) or
inhibitors (RI), may alter to reflect this [92].
doi:10.1371/journal.pgen.1001015.g003
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mammalian models allows us to define the importance of its
conservation and the relevance of any absence of conservation.
Through further focussed research into human imprinting, we will
elucidate the specialised functions of this remarkable transcrip-
tional mechanism in our species.
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